ImmunoGenesis, a biotechnology company focused on developing innovative cancer therapies, has secured a grant of $10.8 million from the Cancer Prevention & Research Institute of Texas...
Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
